Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands-Reference-Cited by-同舟云学术

Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands

Published:2021-02-02 Issue:3 Volume:61 Page:713-721
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Luken Jessie S.¹^ORCID,Folman Claudia C.¹^ORCID,Lukens Michaël V.²,Meekers Johan H.²^ORCID,Ligthart Peter C.¹,Schonewille Henk³⁴^ORCID,Zwaginga Jaap Jan⁵⁶^ORCID,Janssen Mart P.⁷^ORCID,Schoot C. Ellen³⁴^ORCID,Bom Johanna G.⁶⁸^ORCID,Haas Masja¹⁵⁶^ORCID

Affiliation:

1. Department of Immunohematology Diagnostics Sanquin Diagnostic Services Amsterdam The Netherlands

2. Department of Laboratory Medicine University Medical Center Groningen (UMCG) Groningen The Netherlands

3. Department of Experimental Immunohematology Sanquin Research Amsterdam The Netherlands

4. Landsteiner Laboratory University of Amsterdam Amsterdam The Netherlands

5. Department of Immunohematology and Blood Transfusion Leiden University Medical Center Leiden The Netherlands

6. Center for Clinical Transfusion Research Sanquin Research Leiden The Netherlands

7. Transfusion Technology Assessment Department Donor Medicine Research, Sanquin Research Amsterdam The Netherlands

8. Department of Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16276

Reference25 articles.

1. Haemolytic disease of the fetus and newborn

2. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management

3. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization

4. Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth

5. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy*

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching;British Journal of Haematology;2024-09-10

2. Maternal red blood cell alloimmunization prevalence in the United States;Blood Advances;2024-08-15

3. Standard Compared With Extended Red Blood Cell Antigen Matching for Prevention of Subsequent Hemolytic Disease of the Fetus and Newborn;Obstetrics & Gynecology;2024-08-08

4. Erythrocyte antigen kel1 in a new form of disease history;Astrakhan medical journal;2023-12-24

5. Alloimmune hemolytic disease of the fetus and newborn: genetics, structure, and function of the commonly involved erythrocyte antigens;Journal of Perinatology;2023-10-17